What’s more, Sikora et al. (2018) assessed non-invasive markers of intestinal barrier integrity in psoriasis patients, including concentrations of claudin-3, intestinal fatty acid binding protein (I-FABP) in the blood in psoriasis patients and healthy controls. This evidence concerns the gene CLDN3 and psoriasis.